Eligibility to COAPT Trial in the Daily Practice: A Real-World Experience

被引：0
|
作者：
Zancanaro, Edoardo [1 ]
机构：
[1] Osped San Raffaele, Milan, Italy
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2022年 / 80卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-336
引用
收藏
页码：B135 / B136
页数：2
相关论文
共 50 条
  • [31] Real-world experience of apremilast
    Fremlin, G. A.
    Bedlow, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 : 63 - 63
  • [32] Real-World Experience with Ocrelizumab
    Moss, Brandon
    Parrotta, Erica
    Baldassari, Laura
    Cohen, Jeffrey
    Ontaneda, Daniel
    NEUROLOGY, 2019, 92 (15)
  • [33] REAL-WORLD EXPERIENCE IN CHEMISTRY
    MELTON, LA
    SCIENCE, 1994, 266 (5183) : 203 - 204
  • [34] Real-world experience with abiraterone
    Dahut, William L.
    Madan, Ravi A.
    LANCET ONCOLOGY, 2014, 15 (11): : 1188 - 1190
  • [35] A real-world experience: Really?
    Mitchell, R. Scott
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 156 (06): : 2074 - 2075
  • [36] Real-world ice experience
    Backman, Anders
    Marine Technology, 2013, 50 (01) : 8 - 9
  • [37] Real-World Experience with Ocrelizumab
    Moss, Brandon
    Utigard, Erica
    Baldassari, Laura
    Cohen, Jeffrey
    Ontaneda, Daniel
    NEUROLOGY, 2018, 90
  • [38] Education for Real-World Experience
    Sisson, Patrick
    ARCHITECT, 2020, 109 (09): : 66 - 68
  • [39] Real-world eligibility for vericiguat according to trial, guideline, and labelling eligibility criteria: data from the Swedish Heart Failure Registry
    Nguyen, V. N.
    Lindberg, F.
    Dahlstrom, U.
    Lund, L. H.
    Savarese, G.
    EUROPEAN HEART JOURNAL, 2022, 43 : 963 - 963
  • [40] Experience with outcomes research into the real-world effectiveness of novel therapies in Dutch daily practice from the context of conditional reimbursement
    Gaultney, Jennifer G.
    Franken, Margreet G.
    Uyl-de Groot, Carin A.
    Redekop, William K.
    Huijgens, Peter C.
    van der Holt, Bronno
    Lokhorst, Henk M.
    Sonneveld, Pieter
    HEALTH POLICY, 2015, 119 (02) : 186 - 194
12345